70 likes | 158 Views
Symposium on Pneumococcal vaccines: COI Perspectives. Sero -epidemiology. What is new in sero -prevalence of pneumococcal serotypes in the country? Any data on prevalence of non- typable Hib disease?
E N D
Sero-epidemiology • What is new in sero-prevalence of pneumococcal serotypes in the country? • Any data on prevalence of non-typableHib disease? • What are the findings of studies/projects carried out by Wyeth & GSK on pneumo surveillance in the country? • How frequent are serotypes 3, 6A, and 19A?
Efficacy of PCV 13: • Coverage according to latest Indian estimates/publication? • Indian data on efficacy/effectiveness? • Data from neighboring/developing countries? • Any new data from anywhere? • Efficacy against serotypes 3, 6A & 19A? • Any data on PMS
Efficacy of PCV 10: • Coverage according to latest Indian estimates/publication? • Indian data on efficacy/effectiveness? • Data from neighboring/developing countries? • Any new data from anywhere? COMPAS studies? • Efficacy against non-typeableHib? • Any data on PMS
Post-marketing surveillance: Indian perspectives • Data on PCV7 • Any provision/plan to conduct PMS on serotypes replacement
Price structure of new PCVs: • How can they be made more affordable? • Any new Indian vaccine in the pipeline?
Cost-effectiveness analysis • Any published data/study